TNF and cancer: In the C vs. SP comparison, it was determined that TNF, NFKB, and MAPK signaling pathways, along with transcriptional misregulation in cancer and Kaposi sarcoma-associated Epstein–Barr virus infection pathways, were significantly changed cancer-related pathways.